The King's Brief Lnterstitial Lung Disease Questionnaire
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: patient reported outcome measures.
- Who it may be relevant to
- Registry conditions: Interstitial Lung Disease Due to Systemic Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Investigation of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals With Interstitial Lung Involvement Secondary to Rheumatological Diseases
Overview
The aim of this study is to examine the validity and reliability of the Turkish Validity and Reliability of The King's Brief Interstitial Lung Disease Questionnaire (K-BILD) in Individuals with Interstitial Lung Involvement Secondary to Rheumatological Diseases.
Interventions
- Behavioral patient reported outcome measures
King's Brief lnterstitial Lung Disease Questionnaire, Arthritis Impact Measurement Scales (AIMS2)-Short Form, Modified Medical Research Council (mMRC) Dyspnea Scale, Visual Analog Scale were evaluated.
Primary outcome measures
- King's Brief lnterstitial Lung Disease Questionnaire [Time frame: 10 minutes]
Secondary outcome measures (3)
- Arthritis Impact Measurement Scales (AIMS2)-Short Form [Time frame: 15 minutes]
- Modified Medical Research Council (mMRC) Dyspnea Scale [Time frame: 5 minutes]
- Visual Analog Scale [Time frame: 3 minutes]
Eligibility criteria
Inclusion Criteria:-Having been diagnosed with interstitial lung disease by a rheumatologist,
- Being 18 years of age or older,
- Agreeing to participate in the study.
Exclusion Criteria:- Presence of a neurological disease
- Presence of any orthopedic problem that affects functionality
- History of any orthopedic surgery in the last year
- Inability to speak or understand Turkish fluently
- Presence of a psychiatric illness that affects cooperation
- Heart failure that affects daily living activities
- Being a cancer patient
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Turkey (Türkiye) · 1 center
- Usak University — Uşak
Identifiers
NCT: NCT07700004 · Turkish Validity Reliability